Biotech / Pharma
Graybug
Biotech / Pharma
Biopharmaceutical company developing sustained-release therapies for eye diseases including wet AMD and glaucoma; IPO'd in 2020 as Graybug Vision (NASDAQ: GRAY).
Founded
Region
Investors
People